8 hasil untuk "Kumar Ilangovan"
Menampilkan 1–8 · 0,24 detik · RSS
-
Artikel Jurnal
Breast Health Disparities: A Primer for Medical Students
Abstract Introduction While breast cancer incidence rates have remained stable and mortality rates have declined for white women, breast cancer mortality has steadily increased for African American women since the 1950s. It has often been assumed that genetic risks linked to African ancestry are…
-
Artikel Jurnal
Adult RSV Vaccination: What Is the Role of RSV Subgroup in Disease Prevention?
Abstract Respiratory syncytial virus (RSV) cocirculates as two antigenic subgroups, RSV A and RSV B, with irregular dominance by season. Despite highly conserved fusion (F) protein epitopes, sequence, and antigenic differences between A and B, especially within prefusion F, can modulate…
-
Artikel Jurnal
Is a Consensus Case Definition for Viral Associated Lower Respiratory Tract Disease (LRTD) in Clinical Trials Possible?
Abstract Lower respiratory tract illness or disease (LRTI/LRTD) represents a significant source of morbidity and mortality following viral respiratory illnesses, yet a consensus definition for this outcome is lacking. Recent studies of novel vaccines against respiratory syncytial virus (RSV) for…
-
Artikel Jurnal
A qualitative exploration of occupational influences on hydration, urination habits, food patterns, and self-care among patients with urolithiasis
Abstract Background Urolithiasis prevention depends on sustained fluid intake, timely urination, and appropriate dietary and lifestyle practices. However, occupational routines may make these behaviors difficult to maintain. This study explored participants’ perceptions of how occupational routines…
-
Artikel Jurnal Teks lengkap
Integrated Analysis of the Safety Experience in Adults with the Bivalent Respiratory Syncytial Virus Prefusion F Vaccine
Background/objectives: This was a post hoc analysis of safety data across the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine clinical trial development program. Methods: Data from eight clinical trials in 46,913 immunocompetent adults who received RSVpreF or placebo were…
-
Artikel Jurnal
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
BACKGROUND: Respiratory syncytial virus (RSV) infection causes considerable illness in older adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein-based (RSVpreF) vaccine in this population are unknown. METHODS: In this ongoing, phase 3 trial, we randomly assigned…
-
Artikel Jurnal Teks lengkap
Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults
Background/Objectives: Individuals with immunocompromising conditions are at high risk of developing severe respiratory syncytial virus (RSV) illness. This phase 3, single-arm study assessed the safety and immunogenicity of the bivalent RSV prefusion F protein−based (RSVpreF) 120-µg vaccine in…